Adam Quick

Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis

Sabrina Paganoni, Eric A. Macklin, Suzanne Hendrix et al. · New England Journal of Medicine · 2020 · 524 citations · Full text

Medicine, Neurology, Pharmacology +14

Long‐term survival of participants in the <scp>CENTAUR</scp> trial of sodium phenylbutyrate‐taurursodiol in <scp>amyotrophic lateral sclerosis</scp>

Sabrina Paganoni, Suzanne Hendrix, Samuel P. Dickson et al. · Muscle & Nerve · 2020 · 180 citations · Full text

Medicine, Neurology, Pharmacology +15

Defective fast inactivation recovery of <scp>N</scp>a_v1.4 in congenital myasthenic syndrome

W. David Arnold, Daniel H. Feldman, Sandra Ramírez‐Clavijo et al. · Annals of Neurology · 2015 · 67 citations · Full text

Life Sciences, Genetics, Physiology +17

Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial

Sabrina Paganoni, Suzanne Hendrix, Samuel P. Dickson et al. · Journal of Neurology Neurosurgery & Psychiatry · 2022 · 66 citations · Full text

Medicine, Neurology, Pharmacology +13

Risk factors for amyotrophic lateral sclerosis: A regional United States case‐control study

Angeline S. Andrew, Walter G. Bradley, Daniel Peipert et al. · Muscle & Nerve · 2020 · 56 citations · Full text

Public Health, Neurology, Neurodegeneration +13